$ENZN Recent News Cancer drug test results send CytRx

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$ENZN Recent News

Cancer drug test results send CytRx shares soaring by 75% 11:48 a.m. Dec. 11, 2013 - Russ Britt
5 activist hedge funds to watch 12:17 p.m. Oct. 15, 2013 - Insider Monkey
Enzon to partner with China's Hisun 1:06 p.m. May 7, 2012 - MarketWatch.com
Stocks to watch Friday: McDonald’s, TriQuint 7:11 a.m. Sept. 23, 2011 - MarketWatch
Proxy firm backs Forest Labs' entire board slate 12:56 p.m. Aug. 10, 2011 - MarketWatch.com
Monday's biggest gaining and declining stocks 5:41 p.m. Nov. 9, 2009 - MarketWatch
Enzon to sell specialty pharmaceuticals business 9:47 a.m. Nov. 9, 2009 - MarketWatch
Enzon sells specialty pharma business for $327M 9:34 a.m. Nov. 9, 2009 - Michelle Donley
Drug stocks gain, Enzon rises on divestiture news 1:17 p.m. Aug. 11, 2008 - Val Brickates Kennedy
Drug stocks slip, but earnings boost Charles River 2:31 p.m. May 7, 2008 - Val Brickates Kennedy
CORRECT: Carl Icahn acquires 6.93% stake in Enzon 1:12 p.m. March 14, 2008 - Wallace Witkowski
CORRECT:Icahn suggests Enzon consider strategic review, sale 1:08 p.m. March 14, 2008 - Wallace Witkowski
CORRECT: Icahn buys Enzon stake because shares undervalued 1:07 p.m. March 14, 2008 - Wallace Witkowski
CORRECT: Carl Icahn acquires 6.93% stake in Enzon 1:05 p.m. March 14, 2008 - Wallace Witkowski
Drug and biotech shares rise, Palatin jumps on data 9:47 a.m. Sept. 27, 2007 - Angela Moore
Drug stocks flat; Enzon climbs for second day 1:08 p.m. Aug. 21, 2007 - Val Brickates Kennedy
Monday's biggest gaining and declining stocks 4:32 p.m. Aug. 20, 2007 - MarketWatch
Drug stocks mixed; Novo-Nordisk gains on drug data 1:38 p.m. Aug. 20, 2007 - Val Brickates Kennedy
Enzon sells 25% of Peg-intron royalty interest for $93 mln 9:03 a.m. Aug. 20, 2007 - Val Brickates Kennedy
Icahn group discloses investment holdings 8:06 a.m. Aug. 15, 2007 - MarketWatch.com


Tracking Carl Icahn's Portfolio - Q1 2014 Update 1:46 a.m. May 20, 2014 - Seeking Alpha
Baupost's Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals 5:43 p.m. May 12, 2014 - GuruFocus.com
Looking For Value Among Biotechs After Precipitous Declines In Stock Price 12:26 p.m. March 24, 2014 - Seeking Alpha
Tracking Carl Icahn's Portfolio - Q4 2013 Update 1:25 a.m. Feb. 18, 2014 - Seeking Alpha
Tracking Seth Klarman's Baupost Group Holdings - Q4 2013 Update 4:01 a.m. Feb. 14, 2014 - Seeking Alpha
Warning! Enzon Pharmaceuticals Is Definitely Going To $0 8:52 a.m. Jan. 14, 2014 - Seeking Alpha
Ranking 50 Stocks By Free Cash Flow Yield 8:05 a.m. Nov. 26, 2013 - Seeking Alpha
Tracking Carl Icahn's Portfolio - Q3 2013 Update 11:05 a.m. Nov. 18, 2013 - Seeking Alpha
10-Q: ENZON PHARMACEUTICALS INC 5:35 p.m. Nov. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
What's Left Of Enzon Pharmaceuticals? 7:53 a.m. Sept. 30, 2013 - Seeking Alpha
Billionaires Hold Bargains, 40% Off or More 7:14 p.m. Sept. 11, 2013 - GuruFocus.com
Tracking Carl Icahn's Portfolio - Q2 2013 Update 8:03 a.m. Aug. 23, 2013 - Seeking Alpha
Tracking Seth Klarman's Baupost Group Holdings - Q2 2013 Update 12:57 p.m. Aug. 14, 2013 - Seeking Alpha
Charles Brandes Top Second Quarter Portfolio Changes 6:49 p.m. Aug. 9, 2013 - GuruFocus.com
Complete Seth Klarman And Baupost Group Portfolio Update 4:46 p.m. May 15, 2013 - Seeking Alpha
Tracking Seth Klarman's Baupost Group Holdings - Q1 2013 Update 5:33 a.m. May 15, 2013 - Seeking Alpha
Billionaire Seth Klarman's Long-Term Stock Picks 4:04 p.m. May 13, 2013 - Seeking Alpha
Seth Klarman's Worst Performing Stock Picks Year-To-Date 12:35 p.m. May 13, 2013 - Seeking Alpha
10-Q: ENZON PHARMACEUTICALS INC 4:39 p.m. May 10, 2013 - Edgar Online - (EDG = 10Q, 10K)
A Review Of Seth Klarman's Baupost Group's Q4 U.S. Equity Changes 2:58 p.m. Feb. 18, 2013 - Seeking Alpha


Enzon Adopts Stockholder Rights Plan in an Effort to Protect Net Operating Loss Carryforwards 8:32 a.m. May 1, 2014 - BusinessWire - BZX
Annual Changes to the NASDAQ Biotechnology Index 9:05 a.m. Dec. 16, 2013 - GlobeNewswire
Arthur J. Higgins Joins Endo Board of Directors 10:50 p.m. Dec. 10, 2013 - PR Newswire
Santaris Pharma A/S resumes full ownership of cancer programs licensed to Enzon Pharmaceutical Inc. 8:00 a.m. Oct. 28, 2013 - PR Newswire
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 3

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 1

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 2

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 2

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 1

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 1

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 7

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading

Top 5 Most Recently Viewed Articles

Stämm and SuperMeat Join Forces to Innovate Cultivated Meat

Updated Category News Views 152

Revolutionizing Cultivated Meat Production through Collaboration Stämm has recently announced an exciting collaboration with SuperMeat to accelerate developments in cultivated meat biomanufacturing. With Varana Capital's strategic backing, this partnership seeks to enhance SuperMeat's cultivated chicken production process using Stämm's innovative bioreactor...

Continue Reading
Manchester United Reports Declining Fourth Quarter Earnings

Updated Category News Views 124

Manchester United Reports Its Fourth Quarter Results Manchester United PLC (NYSE: MANU) has recently released its fiscal fourth-quarter results for 2024. The numbers show a significant year-on-year sales drop of 15.0%, totaling 142.2 million British pounds, or about $179.43 million. Unfortunately, this result didn't meet analysts' expectations, which had projected sales...

Continue Reading
China's Rural Road Achievements Fuel Sustainable Development

Updated Category News Views 273

China's Rural Road Achievements and Future Vision Recently, the State Council Information Office of China unveiled an insightful white paper titled "China's Rural Roads in the New Era." This document highlights the incredible accomplishments and future aspirations concerning rural road development in the country. The white paper reveals that by the end of 2023, China's...

Continue Reading
Tyson Foods Released Impressive Fourth Quarter Earnings

Updated Category News Views 148

Overview of Fourth Quarter Results Tyson Foods, Inc. (NYSE: TSN), recognized as one of the largest food companies in the world, has showcased impressive financial performance for the fourth quarter of 2025. The company reported sales of $13,860 million, marking a 2.2% increase compared to the corresponding quarter in the previous year. When excluding legal contingency...

Continue Reading
Good Cheer Triumphs at the Renowned Longines Kentucky Oaks

Updated Category News Views 362

Good Cheer Captures the Victory in Kentucky Oaks Excitement filled the air as Good Cheer claimed a notable victory in the Longines Kentucky Oaks, a highlight of the horse racing calendar. This remarkable race saw Good Cheer emerge victorious in a challenging environment with sloppy track conditions, competing against a strong field of 13 fillies. Record-Worthy Wagering at...

Continue Reading